Praxis Medical Insights

General Considerations for Dosing

For patients with chronic kidney disease and Staphylococcus aureus infections related to vascular access, the American College of Physicians recommends monitoring vancomycin trough levels with a target of 15-20 μg/mL, adjusting the dose according to renal function and type of dialysis 1, 2
For severe infections such as bacteremia related to vascular access, the Infectious Diseases Society of America recommends trough concentrations of 15-20 μg/mL to achieve an AUC/MIC >400 1, 2
Trough level monitoring is mandatory in patients with renal dysfunction, including those on dialysis 1, 2

Initial dose: 15-20 mg/kg (actual body weight) every 8-12 hours, not exceeding 2 g per dose, in patients with normal renal function 3
In patients with chronic kidney disease, the dosing interval should be adjusted according to the degree of renal dysfunction 2
For severe infections such as bacteremia, a loading dose of 25-30 mg/kg (actual body weight) may be considered 3

Trough levels should be obtained immediately before the next scheduled hemodialysis session 2
The first trough level should be measured before the second or third maintenance dose 2

Vancomycin trough levels are the most accurate and practical method for guiding dosing 1
Serum trough concentrations should be obtained in steady-state conditions, before the fourth or fifth dose 1
Trough levels should be monitored at least weekly throughout therapy 2
Peak concentration monitoring is not recommended 1

For Staphylococcus aureus infections related to vascular access, treatment is recommended for 4-6 weeks 4, 2
Surgical evaluation for incision and drainage of contiguous sites of infection or abscess should be performed whenever possible 4

High-dose vancomycin use carries a substantial risk of nephrotoxicity, especially in patients with already compromised renal function 1
To prevent red man syndrome and possible anaphylaxis associated with large vancomycin doses, consideration should be given to prolonging the infusion time to 2 hours and using an antihistamine before administration of the loading dose 1

If the patient has not had a clinical or microbiological response to vancomycin despite adequate debridement, an alternative should be considered regardless of the MIC 4
For isolates with a vancomycin MIC >2 μg/mL (VISA or VRSA), an alternative to vancomycin should be used 1, 4
Alternatives include daptomycin at high doses (10 mg/kg/day), linezolid 600 mg PO/IV twice daily, or TMP-SMX 5 mg/kg IV twice daily 4, 2